Gefitinib Sandoz

Gefitinib Sandoz Indications/Uses

gefitinib

Manufacturer:

Sandoz

Distributor:

Zuellig Pharma

Marketer:

Novartis
Full Prescribing Info
Indications/Uses
Gefitinib is indicated for the first line treatment of patients with locally advanced or metastatic Non-Small Cell Lung Cancer (NSCLC) who have activating mutations of the EGFR-TK (see Precautions).
Gefitinib is indicated for the treatment of patients with locally advanced or metastatic NonĀ­ Small Cell Lung Cancer (NSCLC) who have previously received chemotherapy.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in